... treatment modalities, and 133 (37.4%) studies evaluated targeted therapy with(out) chemotherapy (Table  2). We identified no differences in the rate of biomarker testing between studies including UC of the bladder only (Table  3). Table 2. Study characteristics Urothelial bladder cancer...

... and phosphorylated YAP1 (pYAP1) in urothelial bladder cancer (BCA). Materials and Methods: We used a tissue micorarray with samples of patients with muscle-invasive bladder cancer (MIBC, n = 192), non-muscle-invasive bladder cancer (NMIBC, n = 192) and normal urothelial bladder tissue (CTRL, n = 38) to determine...